ライフサイエンスコーパス: m-

1 or placebo-treated patients (difference 13.0 m [SE 10.4], 95% CI -7.4 to 33.4; p=0.213).

2 weeks in patients who received placebo (15.0 m [IQR, -26.0 to 45.0]) or sildenafil (5.0 m [IQR, -37.0

3 Pilot field tests were performed at 3.0 m (shallow test) and 7.9 m (deep test) below ground surf

4 walk test increased with allo-hMSCs by 37.0 m (p = 0.04), but not auto-hMSCs at 7.3 m (p = 0.71; aut

5 0 m [IQR, -26.0 to 45.0]) or sildenafil (5.0 m [IQR, -37.0 to 55.0]; P = .92) were also not significa

6 the testosterone and placebo groups was 54.0 m (95% CI, 43.0-65.0 m), 46.7 m (95% CI, 12.6-80.9 m), a

7 ncy, with measured plate counts of 1,650,000/m +/- 7%, corresponding to a reduced plate height of h =

8 mean velocity was less than or equal to 4.06 m .sec(-1) at axial SWE (sensitivity, 54.2%; 95% confide

9 difference in change from baseline of 35.09 m (95% CI 7.59 to 62.60; p=0.014) versus placebo.

10 ed measurements of equivalent dose rate at 1 m (EDR-1m) from the sternum and urinary bladder were obt

11 At sulfate concentrations greater than 1 m (molal), bidentate sulfate is observed, a coordination

12 i) the reduced monoanions [Ru2-C2m-Ru2](-1) (m = 4-8) belong to the Robin-Day class II mixed valent i

13 2.17 (m = 55) to 1.39 cm(2) x V(-1) x s(-1) (m = 368).

14 the lower symmetry monoclinic subgroup P2(1)/m (#11).

15 ts was defined as cardiac arrests within 100 m (109.4 yd) of an AED and further categorized according

16 ing samples highly enriched with nearly 100% m- and s-SWNTs.

17 all living within a radius of <300 or <1000 m (14% or 58% population) would target 30% or 66% of inf

18 For each 1000-m (3300-ft) increase in altitude above 2500 m (8200 ft),

19 out any deficits (26%) had worse 6MWD = -109 m (95% confidence interval [CI], -175 to -43), London Ch

20 thymetric profiles, covering an area of 1100 m (alongshore) by 440 m (cross-shore).

21 ced 4-m walking speed (-0.0034 versus -0.111 m . s(-1) .

22 es were similar: upslope shifts averaged 113 m (Mt.

23 ced aortic CoQ [22 d (35+/-8.4%; P<0.05); 12 m (53+/-8.8%; P<0.05)], accelerated aortic telomere shor

24 m (250-1999 ft), 214.6 from 610 through 1218 m (2000-3999 ft), 184.9 from 1219 through 1828 m (4000 t

25 Karimui) and 123 m (Karkar Island) for lower limits.

26 om baseline in trough 6MWD at week 12 was 14 m (p = 0.0066).

27 (2005-2008) for persons living less than 150 m (versus more than 300 m) from major roadways, adjustin

28 Karimui) and 152 m (Karkar Island) for upper limits and 95 m (Mt.

29 o sea level (SL), Denver altitude (DA) (1609 m [5280 feet]), and severe high altitude (HYP) ( approxi

30 ow mass ions with K(o) in the range of 2.17 (m = 55) to 1.39 cm(2) x V(-1) x s(-1) (m = 368).

31 tance (399 vs 417 m; absolute difference, 18 m [95% CI, 6-30]; P = .30), after adjustment for age, se

32 ), and 177.2 at an altitude higher than 1828 m (>6000 ft).

33 (2000-3999 ft), 184.9 from 1219 through 1828 m (4000 to 5999 ft), and 177.2 at an altitude higher tha

34 >) ) and AO incorporation (up to 12 % at 0.2 m [AO]) are appreciable.

35 s-Fe(CO)3(P((CH2)mCH horizontal lineCH2)3)2 (m = a/4; b/5, c/6, e/8) and Grubbs' catalyst (12-24 mol

36 vert nonamyloidogenic human wild-type beta(2)m (Hbeta(2)m) into a rare amyloidogenic conformation and

37 on into diphtheria toxin (DT)-treated beta(2)m --> K14-OVA x Langerin-DTR Tg mice resulted in skin GV

38 2)-p-CH(3)C(6)H(4))(4) (1-p-Me), and U(CH(2)-m-(CH(3))(2)C(6)H(3))(4) (1-m-Me(2)) are reported.

39 Inhibiting IP(6) kinase activity using N(2)-(m-(trifluoromethy)lbenzyl) N(6)-(p-nitrobenzyl)purine (T

40 ty risk was high with AVA/height <0.45 cm(2)/m (adjusted HR, 2.18 [1.28-3.71]), followed by AVA/BSA <

41 ], 3.42 [2.09-5.60]), AVA/height <0.45 cm(2)/m (adjusted HR, 3.99 [2.42-6.60]), AVA/weight <0.01 cm(2

42 itochondrial calcium concentration ([Ca(2+) ]m ) was measured at different stimulation frequencies (0

43 eneral formula [Ru(n)(tda)(py)2](m+) (n = 2, m = 0, 1; n = 3, m = 1, 2(+); n = 4, m = 2, 3(2+)), with

44 29)O(102))(4)} (M = Mn, Co, Ni or Zn, n = 2, m = 4; M = Cu, n = 3, m = 5) (5-9).

45 ter samples collected at depths less than 20 m (adjusted R(2) values greater than 0.80) and in soil s

46 Modeled deep water concentrations below 200 m (5-15 pg/L) were slightly higher than measurements (<5

47 (95% CI, -4 m to infinity) (P = .06) and +21 m (95% CI, -5 m to infinity) (P = .12) for 6-minute walk

48 d expiratory volume in the first second, +21 m (95% CI, -4 m to infinity) (P = .06) and +21 m (95% CI

49 ers and (MgH(2))(n) nanocrystals (n = 2-216, m = 2-436) using high level coupled cluster, CCSD(T), ab

50 lood heights increased by approximately 1.24 m (due mainly to sea level rise) from approximately A.D.

51 6 min walk test distance (from a mean of 244 m [SD 112] to 318 m [134]; p=0.016).

52 ted amputation walked on a treadmill at 1.25 m . s(-1).

53 Median 6MWT improvement was 25 m (IQR, 19-47 m).

54 -m (3300-ft) increase in altitude above 2500 m (8200 ft), AMS prevalence increased 13% (95% CI, 9.5%-

55 nstrate a monolithic waveguide as long as 27 m (39 m optical path length), and featuring broadband lo

56 (95% CI: 0.75 to 1.39) for 6MW distance <288 m (bottom tertile).

57 duction in the 6-minute walk distance (-11.3 m [95% CI, -31.7 to 9.7] versus 25.3 m [95% CI, 6.1-44.5

58 p = 0.001) for the younger and 35.9 +/- 18.3 m (p = 0.038) for the older participants (p = NS between

59 (-11.3 m [95% CI, -31.7 to 9.7] versus 25.3 m [95% CI, 6.1-44.5]; P=0.01), an increase in QRS durati

60 e than exercise alone (mean difference, -6.3 m [95% CI, -30.2 to +17.6]; P = .61) or more than GM-CSF

61 37.0 m (p = 0.04), but not auto-hMSCs at 7.3 m (p = 0.71; auto vs. allo p = 0.0168).

62 pping the intervention the effect waned (7.3 m [95% CI -32.5 to 47.0]; p=0.50).

63 u(n)(tda)(py)2](m+) (n = 2, m = 0, 1; n = 3, m = 1, 2(+); n = 4, m = 2, 3(2+)), with tda(2-) being [2

64 , Co, Ni or Zn, n = 2, m = 4; M = Cu, n = 3, m = 5) (5-9).

65 UO2Ac2(H2O)n(MeOH)(m)H(+) (n = 1, 2, 3,...; m = 1, 2, 3,...).

66 hydrophobic photolabel 3-trifluoromethyl-3-(m-[(125)I]iodophenyl)diazirine ([(125)I]TID) was used to

67 mpaction air samples were taken not </=0.305 m (1 foot), 0.914 m (3 feet), and 1.829 m (6 feet) from

68 Baseline preprocedural 6MWT distance was 308 m (interquartile range [IQR], 234-394 m).

69 from non-labouring sea level (n = 3) or 3100 m (n = 3) women.

70 stance (from a mean of 244 m [SD 112] to 318 m [134]; p=0.016).

71 ment effect on 6-minute walk distance was 32 m (95% confidence interval, 12-52; P=0.002), an effect m

72 re than 25% of individuals ascending to 3500 m (11500 ft) and more than 50% of those above 6000 m (19

73 al [CI]: 0.26 to 0.66) for 6MW distance >386 m (top tertile); HR: 0.57 (95% CI: 0.39 to 0.83) for 6MW

74 I: 0.39 to 0.83) for 6MW distance 288 to 386 m (middle tertile); and HR: 1.02 (95% CI: 0.75 to 1.39)

75 n 6MWD in COPDGene subjects with ILA was 386 m (SD, 128 m), and 82% and 19% of subjects with ILA had

76 Complexes 3r,m (and the Nb analogues) as well as 4 establish the feas

77 ion control + placebo (mean difference, -1.4 m [95% CI, -25.2 to +22.4]; P = .91).

78 roup increased their distance walked by 12.4 m (95% CI, -8.42 to 33.3 m; P = .24) compared with the c

79 d an average difference in Delta6MWD of 22.4 m (95% confidence interval, 17.4-27.5 m), favoring activ

80 16.1 to 6.8) for losmapimod 7.5 mg, and -3.4 m (-15.1 to 8.2) for losmapimod 15 mg.

81 12.3-33.3 degrees C) and median depth of 4.4 m (IQR = 19 m; range = 0-452 m).

82 ond, 95% CI: -0.14, -0.08; and betawalking 4 m = -0.08 m/second, 95% CI: -0.10, -0.06).

83 uiv of K(CH(2)Ar) (Ar = Ph, p-CH(3)C(6)H(4), m-(CH(3))(2)C(6)H(3)) to UCl(4) at -108 degrees C produc

84 (n = 2, m = 0, 1; n = 3, m = 1, 2(+); n = 4, m = 2, 3(2+)), with tda(2-) being [2,2':6',2''-terpyridi

85 terval: 1.05, 1.28) than those who lived 416 m (75th percentile) away.

86 vering an area of 1100 m (alongshore) by 440 m (cross-shore).

87 ude (LA) and following active ascent to 4559 m (HA).

88 e walking distance increased from 390 to 467 m (P = .02) 5 months after PEA.

89 een the tadalafil and placebo groups was 0.5 m (95% CI -11.6 to 12.5; p=0.937).

90 At week 25, mean 6MWD had increased by 31.5 m (SE 9.8) from baseline for continuous drisapersen, wit

91 f 300 m or more to less than 400 m, and -9.5 m (17.2, -43.2 to 24.2; p=0.580) in the group with a 6MW

92 00 m(-2) within a depth range of 1,100 1,500 m (overall observed depth range 841-2,266 m).

93 [SE 10.3]) and placebo (mean difference 3.51 m [-24.34 to 31.35]) at week 25.

94 ere high altitude (HYP) ( approximately 5182 m [ approximately 17,000 feet]) for 6 weeks.

95 on emission tomography, gait speed over 4.57 m (15 ft), and cognition on the Mini-Mental State Examin

96 68.5, 81.7) and less than or equal to 14.58 m .sec(-1) at sagittal SWE (sensitivity, 58.3%; 95% CI:

97 After PR 6MWD increased by 56 +/- 58 m (P < 0.001), the physical summary component of SF36 (0

98 Participants who lived 58 m (25th percentile) from major roadways had lower LPR (b

99 are, with a between-group difference of 14.6 m (Hodges-Lehmann 97.5% CI, 0.4 m to infinity; 1-sided P

100 year post-TESI in both groups: 48.5 +/- 14.6 m (p = 0.001) for the younger and 35.9 +/- 18.3 m (p = 0

101 on control + placebo (mean difference, +33.6 m [95% CI, +9.4 to +57.7]; Hochberg-adjusted P = .02).

102 dually increased reaching pre-PH levels at 6 m (0.3 +/- 0.01).

103 n those who lived within 300 m; from 301-600 m (OR = 0.7; 95% CI 0.5-0.9) and from 601-900 m (OR = 0.

104 00 ft) and more than 50% of those above 6000 m (19700 ft).

105 an 76 m (<250 ft), 221.2 from 76 through 609 m (250-1999 ft), 214.6 from 610 through 1218 m (2000-399

106 0 mg in both PHIRST and PHIRST-2 (406 +/- 67 m [n = 52] and 413 +/- 81 m [n = 59] at PHIRST-2 enrollm

107 74-500 bar, and salt concentration range 0-7 m (NaCl equivalent), using 173 published CO(2) solubilit

108 re than GM-CSF alone (mean difference, +28.7 m [95% CI, +5.1 to +52.3]; Hochberg-adjusted P = .052).

109 6MWD fell by 29.7 m (SD, 82.9 m) more among those who died than among surv

110 9.9 to 8.4]; mean difference at 6 weeks 35.7 m [95% CI 10.5 to 60.9]; p=0.005).

111 CI -18.2 to 4.9) for losmapimod 2.5 mg, -4.7 m (-16.1 to 6.8) for losmapimod 7.5 mg, and -3.4 m (-15.

112 roups was 54.0 m (95% CI, 43.0-65.0 m), 46.7 m (95% CI, 12.6-80.9 m), and 2.70 mL/kg per min (95% CI,

113 e in 6MWD from baseline to week 48 was -47.7 m (SE 9.3) for ataluren-treated patients and -60.7 m (9.

114 min walk distance was not significant: -6.7 m (95% CI -18.2 to 4.9) for losmapimod 2.5 mg, -4.7 m (-

115 9.3) for ataluren-treated patients and -60.7 m (9.3) for placebo-treated patients (difference 13.0 m

116 acebo in the prespecified subgroups was -7.7 m (SE 24.1, 95% CI -54.9 to 39.5; p=0.749) in the group

117 : 86.3, 95.1) and less than or equal to 5.70 m .sec(-1) at sagittal SWE (sensitivity, 41.7%; 95% CI:

118 en content was 26% lower than it was at 7100 m (145.8 ml per liter as compared with 197.1 ml per lite

119 , and accuracy using a GFR of 75 mL/min/1.73 m (eSCr75-MDRD) or the median GFR observed in period 1 (

120 higher odds of having eGFR > 60 mL/min/1.73 m (odds ratio, 8.94, 95% CI 2.47-32.25, P = 0.001) and h

121 ance was reduced to less than 40 mL/min/1.73 m (p = 0.01).

122 as 31% greater for eGFR 45 to 59 mL/min/1.73 m (P<0.0001) and 622% greater for eGFR 15 to 30 mL/min/1

123 d 622% greater for eGFR 15 to 30 mL/min/1.73 m (P<0.0001).

124 follow-up was 27.2 +/- 13.1 mL/min per 1.73 m (P<0.001 on paired t test), which represents a 29.2% d

125 ve MDRD-eGFR of less than 60 mL/min per 1.73 m (P=0.021).

126 the 6-minute walk distance was greater by 74 m (95% CI, 47 to 100) (P<0.01 for all comparisons).

127 ears were 220.1 at an altitude lower than 76 m (<250 ft), 221.2 from 76 through 609 m (250-1999 ft),

128 letion (415 +/- 80 m [n = 51] and 410 +/- 78 m [n = 59], respectively).

129 aintained at PHIRST-2 completion (415 +/- 80 m [n = 51] and 410 +/- 78 m [n = 59], respectively).

130 IRST-2 (406 +/- 67 m [n = 52] and 413 +/- 81 m [n = 59] at PHIRST-2 enrollment, respectively) were ma

131 .305 m (1 foot), 0.914 m (3 feet), and 1.829 m (6 feet) from the patient's head during routine care.

132 In four samples taken at 8400 m (27,559 ft)--at which altitude the barometric pressure

133 ions that traversed between 1.83 and 182.86 m (from 1 to 100 cycles).

134 mean velocity was less than or equal to 4.86 m .sec(-1) at axial SWE (sensitivity, 66.7%; 95% CI: 44.

135 ource, whereas 90% reduction was found at 88 m (maximum) depending on the direction of the pollen-rec

136 limbers at the summit of Mount Everest (8848 m [29,029 ft]) is close to the limit of tolerance by hum

137 roup increased their distance walked by 35.9 m (95% confidence interval [CI], 15.3-56.5 m; P < .001)

138 e group with a 6MWD of less than 300 m, 42.9 m (15.9, 11.8-74.0; p=0.007) in the group with a 6MWD of

139 re performed at 3.0 m (shallow test) and 7.9 m (deep test) below ground surface within distinct litho

140 m AMH levels across a set of approximately 9 m '1000 Genomes Reference Panel' imputed genetic variant

141 (OR = 0.7; 95% CI 0.5-0.9) and from 601-900 m (OR = 0.6; 95% CI 0.4-0.8).

142 es were taken not </=0.305 m (1 foot), 0.914 m (3 feet), and 1.829 m (6 feet) from the patient's head

143 52 m (Karkar Island) for upper limits and 95 m (Mt.

144 erall, the mean transmission distance was 95 m (95% CI: 77-113 m).

145 l assembly process corresponds to about 0.95(m - 1) for arrays containing m tiles.

146 paragine, L-Aspartic Acid, L- Glutamic Acid, m- Erythritol, D-Melezitose, D-Sorbitol) triggered the f

147 rming behavior is strong evidence that Aibm (m >/= 10) building blocks can span bilayers.

148 rtex modes with topological charge m = 1 and m = 2 with a conversion efficiency as large as 60%.

149 ary of (3,4,5)nG1-m-PBI with n = 12 to 6 and m = 1 are reported.

150 2, n = 14 (1a-d); m = 2, n = 15 (2a,b); and m = 3, n = 15 (3).

151 ility indices m = 14 for the low-density and m = 20-25 for the high-density liquid.

152 elicited mild OD shifts in both control and m-/p+ mice; however, the OD shifts in m-/p+ mice lacked

153 Sr(6)Co(5)O(15) are the (m = 2, n = 3) and (m = 1, n = 1) members of the A(3m+3n)A'(n)B(3m+n)O(9m+6n

154 Both m- and mu-calpain were capable of cleaving immunoprecipi

155 tructurally in the monoclinic space group C2/m (no.12) and adopt the MnSb(2)Se(4) structure type.

156 the fundamental mode with topological charge m = 0 can be converted to plasmon vortex modes with topo

157 plasmon vortex modes with topological charge m = 1 and m = 2 with a conversion efficiency as large as

158 h an unprecedented cooperativity coefficient m = 3.37.

159 large survival differences were considered (m = 20), the Delta(m) was positive (Delta[20] = 8.9%; 95

160 d in primary muscle cells derived from Cpt1b(m-/-) mice.

161 ids in skeletal muscle is repressed in Cpt1b(m-/-) mice, strongly supporting the hypothesis that mito

162 -signalling pathways were decreased in Cpt1b(m-/-) muscle.

163 r, was increased in skeletal muscle of Cpt1b(m-/-) mice.

164 s decreased in white adipose tissue of Cpt1b(m-/-) mice.

165 cally distinct clusters on the surface, (Cu) m ,(Ag) n |polymer|glassy carbon electrode (GCE), as sho

166 een synthesized, where m = 2, n = 14 (1a-d); m = 2, n = 15 (2a,b); and m = 3, n = 15 (3).

167 ual cortex (VC) of Ube3a maternal-deficient (m-/p+) mice.

168 g a self-interaction cross section sigma(DM)/m < 0.47 cm(2)/g (95% CL) and disfavoring some proposed

169 its self-interaction cross section sigma(DM)/m < 1.25 square centimeters per gram (cm(2)/g) [68% conf

170 The two highly enriched m- and s-SWNT samples clearly exhibited features for m-

171 over a wide range of modulation frequency, f m = 150 MHz-1 GHz.

172 For m = 0, 2, 3, 4 ,they consist of tetramers as basic units

173 In contrast, for m = 1, there is only one molecule in each stratum, with

174 -SWNT samples clearly exhibited features for m- and s-SNWT (13)C nuclei (approximately 123 and 122 pp

175 )C NMR was found to be a sensitive probe for m- and s-SWNTs in mixed SWNT samples with diameters of a

176 The lamellar crystals self-organized from m = 1 and the two highly ordered columnar hexagonal peri

177 tates generates a higher transconductance (g m ) and unity current gain cut-off frequency (f T ) than

178 We tested how this Gabrb3 m-/p+ mutation affects CbN physiology in mice, separatin

179 5O68.(H2O)m]n (1, X = Si, m = 35; 2, X = Ge, m = 41), and the molecular tetramer Na6[{Na(mu-OH2)(OH2)

180 n)CN]H (n = 1-5), and Tp'RhL[(CH(2))(m)Cl]H (m = 1, 3, 4, 5).

181 l catalytically active mammalian (h = human, m = murine) CA isoforms, from CA I to CA XV.

182 d formation conditions attributed to h-, i-, m-, and n-nanodiamond polymorphs has resulted in their r

183 notopy and visual acuity that we observed in m-/p+ mice, but was fully established by the onset of th

184 longed MD elicited significant plasticity in m-/p+ mice that never matched the level seen in control

185 ol and m-/p+ mice; however, the OD shifts in m-/p+ mice lacked the strengthening of visual responses

186 es of water and to extract fragility indices m = 14 for the low-density and m = 20-25 for the high-de

187 increases in V max (enzyme production) and K m (indicative of competitive inhibition).

188 ompetitive inhibition (decreased V max and K m ) occurred in surface peat explained by variation in h

189 m = 0.56 microM(-1)s(-1)) than NPP (k cat /K m = 0.044 microM(-1)s(-1)).

190 e was over ten fold higher for GPP (k cat /K m = 0.56 microM(-1)s(-1)) than NPP (k cat /K m = 0.044 m

191 precursor) primarily to 1,8-cineole with K ( m ) and k ( cat ) values of 5.75 muM and 8.8 x 10(-3) s(

192 ery, the preoperative BMI of 32.8 +/- 2.1 kg/m (mean +/- standard deviation) dropped to 25.6 +/- 2.5

193 mean body mass index loss of -7.8 +/- 5.1 kg/m (total weight loss: 16.8% +/- 9.7%) was associated wit

194 raft failure in RTR with BMI less than 25 kg/m (hazard ratio [HR], 0.64 [0.28-1.50] and 0.27 [0.09-0.

195 30 kg/m or more with BMI of less than 25 kg/m (OR: 1.6, CI: 0.8-3.5), ever smokers with never smoker

196 atients with body mass index less than 25 kg/m (p = 0.004) and for body mass index greater than or eq

197 P = 0.023), body mass index (BMI) over 25 kg/m (P = 0.02), retro-renal fat thickness over 15 mm (P =

198 dy mass index greater than or equal to 25 kg/m (p = 0.023).

199 body mass index more than or equal to 30 kg/m (aHR=2.17), and use of tacrolimus (aHR=1.51).

200 o those with body mass index less than 35 kg/m (31.5 +/- 15.6 and 24.7 +/- 11.0 mL/min/1.73 m, respec

201 ass index was greater than or equal to 35 kg/m (n=14) were found to have an absolute decrement in MDR

202 edian upper limit in these centers was 35 kg/m (range, 31-40).

203 ge was 58, with mean body mass index 34.4 kg/m (range 20-65).

204 e of a 35-year-old woman with a BMI of 42 kg/m (96.8 kg) and ESRD, who underwent combined robot-assis

205 andard deviation) dropped to 25.6 +/- 2.5 kg/m (P < 0.001).

206 recommended for patients with BMI >/= 50 kg/m (grade C), current smokers (grade A), or patients with

207 recommended for patients with BMI >/= 50 kg/m (grade C), current smokers (grade A), or patients with

208 rved at room temperature (note that when l = m = 1 these interactions become long, multicenter bonds)

209 series of intermediate clusters of LinBnHm (m </= 4n).

210 )n, and Li2BnHn; off-stoichiometric LinBnHm (m </= 4n) clusters were considered for n = 2, 3, and 6.

211 sters Al(n)Mg(m)(-) (4 </= n+m </= 15; 0 </= m </= 3).

212 nds of ([SnSe]1+delta)m(NbSe2)n, where 1 </= m = n </= 20, with the same atomic composition but diffe

213 The spectra of the (CO(2))(m)(-) (m = 5 and 7) clusters are presented for the first time i

214 (API), chlorpheniramine maleate, at the 2% m/m (4 mg) level.

215 m/s for functionalized molecules with a mass m = 10,000 Da.

216 contains mixtures of s-SWCNTs and metallic- (m-) SWCNTs with wide diameter distributions, typically i

217 Birch reductive alkylation of methyl m-(hydroxymethyl)benzoate derivatives, using lithium in

218 6% (10% to 30%), cardiac index was 1.3 L/min/m (0.7-2.2 ) and systemic resistance vascular index was

219 .47 +/- 0.86 L/min/m2 to 3.28 +/- 0.76 L/min/m (p = .04), indicating a decrease in venous return.

220 ization (2.21 L/min [+/- 0.97] and 1.2 L/min/m [+/- 0.52]).

221 rthorhombic (m = 0, 2, 3, 4) and monoclinic (m = 1) columnar arrays with 3D periodicity.

222 er of drusen in the central 1000 and 3000 mu m (P < 0.05) and the absolute number of drusen >/=125 mi

223 Our studies on Co6Te8(PEt3)m(CO)n (m + n = 6) clusters show that Co6Te8(PEt3)6 has a closed

224 alloy metal clusters Al(n)Mg(m)(-) (4 </= n+m </= 15; 0 </= m </= 3).

225 ubunits that form active alpha(n)beta(m) (n, m = 2 or 6) complexes.

226 -salt-type Pb(m)Sb(2n)Te(m+3n) nanocrystals (m = 2, 3, 4, 6, 8, and 10; n = 1 and 2) were successfull

227 series of Pb(m)Sb(2n)Se(m+3n) nanocrystals (m = 2, 4, 6 and 8; n = 1) are demonstrated that exist on

228 g these crystals to a specific layer number (m = 1-10).

229 tude planetary waves with zonal wave numbers m = 6, 7, and 8.

230 Those patterns--with zonal wave numbers m = 6, 7, or 8--are characteristic of the above extremes

231 Time complexity of each iteration is O(m (3) k) for an m x k SNP matrix where m and k are the n

232 Attempts to make larger ring systems (Z = O, m = 2; Z = O, n = 5; or Z = NTs, n = 4-5) or prepare lac

233 uding pyrazolyl-substituted anilines and o-, m-, and p-phenylenediamine as pi-conjugated spacers.

234 or benzamide bonds were prepared (i.e., o-, m-, p-poly-1 and poly-2 series) and characterized both i

235 The Suzuki-Miyaura couplings of o-, m-, and p-halophenols with o-, m-, and p-phenol boronic

236 Structures and energetics of o-, m-, and p-quinonimide anions (OC6H4N(-)) and quinoniminy

237 is varied systematically using a pair of o-, m-, or p-xylylene (o-, m-, or p-Xy) covalent linkers to

238 The dianions are analogous to o-, m-, and p-benzyne and have the special feature of distin

239 plings of o-, m-, and p-halophenols with o-, m-, and p-phenol boronic acids were investigated for all

240 y using a pair of o-, m-, or p-xylylene (o-, m-, or p-Xy) covalent linkers to produce o-ExBox(4+) (3.

241 rdered columnar hexagonal periodic arrays of m = 3 are assembled via thermodynamically controlled pro

242 sruptive up-down alteration from the case of m = 0, 2, 3, 4.

243 of 1.217(6) nm as a function of one unit of m = n was observed.

244 Oxidation of m- and p-substituted benzylidene fluorenes to antiaromat

245 ctinyl peroxide cage cluster, Li48+m K12 (OH)m [UO2 (O2 )(OH)]60 (H2 O)n (m approximately 20 and n ap

246 te the chemical shift of nanotube carbons on m- and s-SWNTs (metallic and semiconducting single-walle

247 lope (log scale) was not different from one (m = 0.992).

248 e other ring, where X = o-MeO or p-alkyl, or m- or p-EWG; e.g., 4-methoxy-4'-trifluoromethylstilbene)

249 ent: (I) CaAu(4)(Au(1-m)Bi(m)) with 0 < or = m < or = 0.15(1), (II) 0.33(1) < or = m < or = 0.64(1),

250 < or = m < or = 0.15(1), (II) 0.33(1) < or = m < or = 0.64(1), (III) 0.85(4) < or = m < or = 0.90(2);

251 or = m < or = 0.64(1), (III) 0.85(4) < or = m < or = 0.90(2); (IV) (Ca(1-r)Au(r))Au(4)(Bi(1-s)Au(s))

252 annealed at 500 degrees C, the higher order m = n compounds were found to convert to the thermodynam

253 At low temperature, they form orthorhombic (m = 0, 2, 3, 4) and monoclinic (m = 1) columnar arrays w

254 ted that the muscarinic agonist oxotremorine-m (oxo-m) blocks the induction of presynaptic long-term

255 and belongs to the tetragonal space group P4/m (no.

256 approximately 0.48 forms in space group P42/m (a = 8.718(3)A, c = 6.719(2)A; Z = 2) with a new stuff

257 ses of P. subcapitata exposed to high purity m- and s-SWCNT fractions.

258 nd the intrinsic rate of natural increase (r m ) was higher on well-fertilized than under-fertilized

259 fference was considered clinically relevant (m = 0 months).

260 ger than 20 months were considered relevant (m = 20), the net chance of a longer survival was very cl

261 We assessed the vacA signal s-, m-, i-, and d-region genotypes and cagA status in H. pyl

262 y compared with the presence of the vacA s-, m-, and i-region genotypes in Western countries.

263 Conductivities as high as 5x10(6) S/m (12% of bulk Au) were attained after sintering was con

264 rks, [Na7X2W18Sn9Cl5O68.(H2O)m]n (1, X = Si, m = 35; 2, X = Ge, m = 41), and the molecular tetramer N

265 The slope {m = [dDeltaG(ND)([C])]/(d[C])}, is nearly constant.

266 Dual element isotope slopes m = Deltadelta(13)C/ Deltadelta(37)Cl approximately epsi

267 polymer such as Au10(SR)10 to larger Aun(SR)m (n > m) clusters that have only the staple motifs and

268 tricyclic [5,6,5]- through [5,9,5]-systems (m = 1, n = 1-4) are available with the [5,7,5]- and [5,8

269 esulting in thermal destabilization (Delta T m - 10 degrees C per lesion).

270 most stable known triple helices, having T ( m ) values that are increased by > 50 degrees C.

271 Sr(5)Co(4)O(12) and Sr(6)Co(5)O(15) are the (m = 2, n = 3) and (m = 1, n = 1) members of the A(3m+3n)

272 he fourth cysteine can appear in any of the (m + n + o + p) randomized amino acid positions (X).

273 e groups of the NBI via one, two, and three (m = 1, 2, 3) methylenic units.

274 y reduces the addressing lines from m x n to m + n.

275 of passed charges to very high orders (up to m = 15) for electron transport through a quantum dot.

276 medial and the lateral antennal lobe tracts (m- and l-ALT), separately arborizing two antennal lobe h

277 bal deletion of maternal Ube3a allele; Ube3a(m-/p+)).

278 In Ube3a knockdown cell lines and UBE3A(m-/p+) cortical neurons, the GA is severely under-acidif

279 gi apparatus (GA) in the cortex of AS (UBE3A(m-/p+)) mice.

280 ron type-specific synaptic deficits in Ube3a(m-/p+) mice despite the presence of Ube3a in all neurons

281 cal pyramidal neurons is diminished in Ube3a(m-/p+) mice, seemingly at odds with enhanced seizure sus

282 neurons is more severely decreased in Ube3a(m-/p+) mice.

283 l cortex of control and AS model mice (Ube3a(m-/p+) mice).

284 e we extend evidence in AS model mice (Ube3a(m-/p+)) of paternal UBE3A expression within the suprachi

285 carry a maternal Ube3a null mutation (Ube3a(m-/p+)), recapitulate major features of AS in humans, in

286 inates UBE3A protein from the brain of Ube3a(m-/p+) mice, because the paternal allele is epigenetical

287 was enhanced in hippocampal slices of Ube3A(m-/p+) mice, which model AS.

288 Specifically, Ube3a(m-/p+) mice have a markedly reduced capacity to accumula

289 in a mouse model of Angelman syndrome (Ube3a(m-/p+) mice).

290 AS model mice lacking maternal Ube3a (Ube3a(m-/p+) mice) exhibit behavioral deficits that correlated

291 Unexpectedly, Ube3a(m-/p+) mice exhibited increased dopamine release in the

292 We found that while Ube3a(m-/p+) mice maintained relatively normal circadian rhyth

293 s linearly with pressure and reaches 59.2 W/(m .

294 of pristine MgSiO3 pv is found to be 10.7 W/(m .

295 on (cAS, in mol kg(-1) aerosol liquid water, m = molality) and sulfate ionic strength, I(SO4(2-)) (m)

296 1,3-diyne units have been synthesized, where m = 2, n = 14 (1a-d); m = 2, n = 15 (2a,b); and m = 3, n

297 orinated groups and the dendronized NBI with m = 1 and 2 self-organize into lamellar crystals.

298 The dendronized NBI with m = 3 self-assembles into an unprecedentedly complex and

299 This allows the generation of 3 x (m + n + o + p) different peptide topologies because the

300 rifluoromethyl)-4,5-dihydro-1H-pyrazol-1-yl](m- tolyl)methanone (16), which displayed a minimum inhib